Compare ImmunityBio Inc. Common Stock (IBRX) vs Venture Global Inc. Class A common stock (VG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Venture Global Inc. Class A common stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B), while Venture Global Inc. Class A common stock trades at $13.17 (market cap $33.23B). The key difference: Venture Global Inc. Class A common stock is far larger — about 3.2× ImmunityBio Inc. Common Stock's market cap, and Venture Global Inc. Class A common stock pays a 1.2% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Venture Global Inc. Class A common stock for 1 Days on average.
| IBRX | VG | |
|---|---|---|
Market Cap | $10.51B | $33.23B |
Volume | 10,445,785 | 12,625,066 |
Sector | Health | Energy |
52-Week High | $11.55 | $17.53 |
52-Week Low | $1.98 | $5.92 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $72.61B |
Dividend Yield | — | 1.2% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Venture Global Inc. Class A common stock
Venture Global develops, builds, and operates liquefied natural gas export facilities. Its projects connect U.S. natural gas supply with global LNG markets.
Read more on VG →
